http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140057216-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f9b0a5a62d169b27b870c5ed2bd23ad |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V40-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2021-0077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4082 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate | 2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_721d2cf2c1c345e8f8c0a2a8094b181d |
| publicationDate | 2014-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140057216-A |
| titleOfInvention | Methods for the prevention and treatment of exercise-related neurological conditions |
| abstract | The present invention relates to the use of a combination of conventional therapies for exercise-related neurological conditions to adjust the levels of melatonin and / or dopamine in the body of a subject, such as the use of visual phototherapy in conjunction with a medication plan, And to a method of preventing or treating a related neurological condition. Visual phototherapy can include elevated levels of blue-green light or green light (e.g., light in the wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.) have. Visual phototherapy may also include reduced levels of orange, orange, and / or red light. Methods of diagnosing exercise-related neurological conditions include the use of visual phototherapy to temporarily display one or more signs of any exercise-related neurological condition in a subject already having or expecting to have exercise-related conditions . These indications are temporarily increased so that the indications can be manifested by visual administration of light comprising an increased amount of orange, orange and / or red light. |
| priorityDate | 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.